CLICK HERE FOR MORE INFORMATION

NEW LEGISLATIVE REQUIREMENTS - Featured Regulatory Perspective
Navigating Vermont's Recently Passed S.88 Bill: The Disclosure and Reporting Process for All Samples Disseminated in Vermont

• Why you should have already begun tracking your distributed samples
• How the sample reporting system was deisgned and how it will work
• Differences between the Vermont law and the Patient Protection & Affordable Care Act of 2010
  

Wendy Morgan, Assistant Attorney General, VERMONT ATTORNEY GENERAL'S OFFICE

DISTRIBUTION STRATEGY
UCB CASE STUDY
Measuring the Impact of the Sales Force in a Controlled Versus Non-Controlled Regulatory Environment

• Background, Goals and Structure for the Exercise
  • Balancing business and compliance requirements
  • Successfully identifying and avoiding potential pitfalls
• Measuring Launch Success
  • Balancing promotion of controlled vs. non-controlled
  • Maximizing AOR completions
  • Analyzing controlled eligible HCPs vs. voucher only States
• Ongoing Advantages
  • Minimizing sample costs
  • Covering vacant territories and white space
  • Sampling no-see prescribers
    

James Corbett, Manager, Field Technology, UCB, INC.